Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system (CNS) drugs. Its structure supports the formation of bioactive molecules due to the presence of the piperazine ring and the oxetane moiety, which can enhance metabolic stability and solubility. Commonly employed in medicinal chemistry for optimizing drug candidates, especially in the design of receptor agonists or antagonists. Also utilized in the preparation of novel compounds for research in neuropharmacology and oncology.